Back

Unsolved issues in oral anticoagulation treatment in atrial fibrillation

European Heart Journal - Cardiovascular Pharmacotherapy

14 March 2019
Organised by: Logo
Read full article
ESC Journals

Contributors

Stefan Agewall
Stefan Agewall

Author

Karolinska Institute Stockholm , Sweden

You may be interested in
thumbnail
Congress Presentation
Adherence and treatment satisfaction among atrial fibrillation patients treated with VKAs versus NOACs: real-world data from a single-center cohort
12 April 2026
thumbnail
Congress Presentation
Exploring the feasibility of discontinuing oral anticoagulant therapy in post-ablation atrial fibrillation patients with low stroke risk: a conceptual inquiry
1 April 2025
thumbnail
Congress Presentation
The management of anticoagulants in patients with atrial fibrillation and history of falls or risk of falls: The Liverpool AF-Falls Project. A systematic review and meta-analysis
4 April 2022
thumbnail
Congress Presentation
A new clinical decision support tool based on personalized evidence-based medicine improves outcomes of anticoagulation therapy in patients with atrial fibrillation: an analysis from the AF Registry
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources